Infinity Z Score
INFI   USA Stock  USD 0.58 0.01 1.75% 
Infinity  Z Score 
Infinity Z Score Analysis
Infinity Pharmaceuti's ZScore is a simple linear, multifactor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..2019  2020  2021  2022 (projected)  
Interest Expense  2.56 M  2.44 M  180 K  184.74 K 
Gross Profit  3.05 M  1.72 M  1.86 M  1.91 M 
Z Score  =  Sum Of   5 Factors 
Current Infinity Pharmaceuti Z Score  20.0 
Most of Infinity Pharmaceuti's fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Infinity Pharmaceuti is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
 
 
 
 

Infinity Z Score Driver Correlations
Understanding the fundamental principles of building solid financial models for Infinity Pharmaceuti is extremely important. It helps to project a fair market value of Ford stock properly, considering its historical fundamentals such as Z Score. Since Infinity Pharmaceuti's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Infinity Pharmaceuti's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Infinity Pharmaceuti's interrelated accounts and indicators.
Click cells to compare fundamentals
To calculate ZScore one would need to know current working capital of the company, its total assets, and liabilities, amount of latest retained earnings as well as earnings before interest and tax. ZScore can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with ZScores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a socalled 'grey area' with scores of less than 1, indicating the high probability of distress. Z Score is used widely by financial auditors, accountants, money managers, loan processers, wealth advisers, as well as day traders. In the last 25 years, many financial models that utilize z score has been proved to be successful as a predictor of corporate bankruptcy.
Compare to competition 
According to the company's disclosures, Infinity Pharmaceuti has a Z Score of 20.0. This is 196.3% higher than that of the Healthcare sector and notably higher than that of the Biotechnology industry. The z score for all United States stocks is 129.36% lower than that of the firm.
Infinity Z Score Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Infinity Pharmaceuti's direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Infinity Pharmaceuti could also be used in its relative valuation, which is a method of valuing Infinity Pharmaceuti by comparing valuation metrics of similar companies.Infinity Pharmaceuti is currently under evaluation in z score category among related companies.
Infinity Pharmaceuti Current Valuation Drivers
We derive many important indicators used in calculating different scores of Infinity Pharmaceuti from analyzing Infinity Pharmaceuti's financial statements. These drivers represent accounts that assess Infinity Pharmaceuti's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Infinity Pharmaceuti's important valuation drivers and their relationship over time.
2017  2018  2019  2020  2021  2022 (projected)  
Net Income Per Employee  (1.9 M)  (450.12 K)  (1.88 M)  (1.76 M)  (2.02 M)  (2.07 M)  
Revenue Per Employee  272.73 K  885.84 K  121.96 K  74.53 K  85.72 K  87.97 K  
Average Assets  79.52 M  56.84 M  62.83 M  48.01 M  98.6 M  115.5 M  
Earnings Before Interest Taxes and Depreciation Amortization EBITDA  (39.83 M)  (10.97 M)  (44.33 M)  (37.56 M)  (44.6 M)  (48.12 M)  
Earnings Before Interest Taxes and Depreciation Amortization USD  (39.83 M)  (10.97 M)  (44.33 M)  (37.56 M)  (44.6 M)  (48.12 M)  
Earnings before Tax  (42.55 M)  (11.25 M)  (47.11 M)  (40.49 M)  (45.26 M)  (48.84 M)  
Average Equity  58.45 M  50.8 M  23.83 M  (12.69 M)  36.83 M  55.8 M  
Enterprise Value  75.36 M  34.89 M  34.8 M  119.15 M  111.25 M  114.18 M  
Free Cash Flow  (36 M)  (4.71 M)  (43.86 M)  (35.78 M)  (40.63 M)  (43.84 M)  
Invested Capital  19.15 M  3.88 M  18.98 M  1.11 M  (8.32 M)  (8.54 M)  
Invested Capital Average  29 M  10.69 M  20.72 M  13.29 M  (5.41 M)  (5.55 M)  
Market Capitalization  102.94 M  67.1 M  54.75 M  136.12 M  200.28 M  263.12 M  
Tangible Asset Value  59.35 M  60.22 M  49.01 M  39.32 M  84.78 M  112.27 M  
Working Capital  46.79 M  52.1 M  34.88 M  24.97 M  68.97 M  89.22 M 
Infinity Pharmaceuti Institutional Holders
Institutional Holdings refers to the ownership stake in Infinity Pharmaceuti that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Infinity Pharmaceuti's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in highprofile magazines, and presentations at investor conferences help move the stock higher, increasing Infinity Pharmaceuti's value.Security Type  Shares  Value  
Blackrock Inc  Common Shares  6.6 M  7.5 M  
Bvf Inc  Common Shares  6.4 M  7.2 M  
Vanguard Group Inc  Common Shares  5.8 M  6.6 M  
Polar Capital Holdings Plc  Common Shares  5 M  5.7 M  
State Street Corp  Common Shares  1.9 M  2.1 M  
Geode Capital Management Llc  Common Shares  1.4 M  1.6 M  
D E Shaw Co Inc  Common Shares  1.1 M  1.3 M 
Infinity Fundamentals
Return On Equity  (490.76) %  
Return On Asset  (45.41) %  
Current Valuation  (8.93 M)  
Shares Outstanding  89.02 M  
Shares Owned by Insiders  1.17 %  
Shares Owned by Institutions  48.79 %  
Number of Shares Shorted  4.66 M  
Price to Earning  (1.63) X  
Price to Book  1.74 X  
Price to Sales  30.02 X  
Revenue  1.86 M  
Gross Profit  (30.91 M)  
EBITDA  (44.6 M)  
Net Income  (45.26 M)  
Cash and Equivalents  80.73 M  
Cash per Share  0.90 X  
Total Debt  1.44 M  
Debt to Equity  0.07 %  
Current Ratio  6.19 X  
Book Value Per Share  0.36 X  
Cash Flow from Operations  (40.62 M)  
Short Ratio  5.54 X  
Earnings Per Share  (0.56) X  
Price to Earnings To Growth  (0.01) X  
Number of Employees  23  
Beta  2.08  
Market Capitalization  55.78 M  
Total Asset  288.82 M  
Retained Earnings  (783.13 M)  
Working Capital  184.64 M  
Current Asset  254.7 M  
Current Liabilities  70.06 M  
Z Score  20.0 
About Infinity Pharmaceuti Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Infinity Pharmaceuti's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Infinity Pharmaceuti using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Infinity Pharmaceuti based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Infinity Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in Cambridge, Massachusetts. Infinity Pharmaceuti operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Infinity Pharmaceuti without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.riskadjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Fund Screener Now
Fund ScreenerFind activelytraded funds from around the world traded on over 30 global exchanges 
All Next  Launch Module 
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Infinity Pharmaceuti using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Please see Infinity Pharmaceuti Piotroski F Score and Infinity Pharmaceuti Valuation analysis. Note that the Infinity Pharmaceuti information on this page should be used as a complementary analysis to other Infinity Pharmaceuti's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Performance Analysis module to check effects of meanvariance optimization against your current asset allocation.
Complementary Tools for Infinity Stock analysis
When running Infinity Pharmaceuti price analysis, check to measure Infinity Pharmaceuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Infinity Pharmaceuti is operating at the current time. Most of Infinity Pharmaceuti's value examination focuses on studying past and present price action to predict the probability of Infinity Pharmaceuti's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Infinity Pharmaceuti's price. Additionally, you may evaluate how the addition of Infinity Pharmaceuti to your portfolios can decrease your overall portfolio volatility.
Portfolio VolatilityCheck portfolio volatility and analyze historical return density to properly model market risk  Go  
Transaction HistoryView history of all your transactions and understand their impact on performance  Go  
Commodity Channel IndexUse Commodity Channel Index to analyze current equity momentum  Go  
Equity AnalysisResearch over 250,000 global equities including funds, stocks and ETFs to find investment opportunities  Go  
Correlation AnalysisReduce portfolio risk simply by holding instruments which are not perfectly correlated  Go  
Shere PortfolioTrack or share privately all of your investments from the convenience of any device  Go 
The market value of Infinity Pharmaceuti is measured differently than its book value, which is the value of Infinity that is recorded on the company's balance sheet. Investors also form their own opinion of Infinity Pharmaceuti's value that differs from its market value or its book value, called intrinsic value, which is Infinity Pharmaceuti's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Infinity Pharmaceuti's market value can be influenced by many factors that don't directly affect Infinity Pharmaceuti's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Infinity Pharmaceuti's value and its price as these two are different measures arrived at by different means. Investors typically determine Infinity Pharmaceuti value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Infinity Pharmaceuti's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.